Literature DB >> 22639855

Analysis of F9 point mutations and their correlation to severity of haemophilia B disease.

N Hamasaki-Katagiri1, R Salari, V L Simhadri, S C Tseng, E Needlman, N C Edwards, Z E Sauna, V Grigoryan, A A Komar, T M Przytycka, C Kimchi-Sarfaty.   

Abstract

Haemophilia B is an X-linked recessive disorder caused by deficiency of functional coagulation factor IX, which results almost exclusively from mutations in the F9 gene. We sought to determine features, which could distinguish between mutations that cause severe disease symptoms from those that cause non-severe disease symptoms. Towards this objective, we have performed a statistical analysis of reported point mutations in F9. These include: potential local changes in mRNA free energy, codon usage, charge and type of mutated amino acid, location of the mutation with regard to protein secondary structure and functional domain and amino acids' evolutionary conservation scores. Wilcoxon signed-rank tests showed highly significant differences between severe and non-severe disease causing mutations in their effect on free energy of small mRNA fragments and evolutionarily conserved amino acids. Our results suggest that information at the mRNA level as well as conservation of the amino acid correlate well with disease severity. This study demonstrates that computational tools may be used to characterize the severity of haemophilia B associated with point mutations and suggests their utility in predicting the outcome of sequence changes in recombinant proteins.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22639855     DOI: 10.1111/j.1365-2516.2012.02848.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  5 in total

1.  Single synonymous mutation in factor IX alters protein properties and underlies haemophilia B.

Authors:  Vijaya L Simhadri; Nobuko Hamasaki-Katagiri; Brian C Lin; Ryan Hunt; Sujata Jha; Sandra C Tseng; Andrew Wu; Amber A Bentley; Ran Zichel; Qi Lu; Lily Zhu; Darón I Freedberg; Dougald M Monroe; Zuben E Sauna; Robert Peters; Anton A Komar; Chava Kimchi-Sarfaty
Journal:  J Med Genet       Date:  2016-12-22       Impact factor: 6.318

2.  A gene-specific method for predicting hemophilia-causing point mutations.

Authors:  Nobuko Hamasaki-Katagiri; Raheleh Salari; Andrew Wu; Yini Qi; Tal Schiller; Amanda C Filiberto; Enrique F Schisterman; Anton A Komar; Teresa M Przytycka; Chava Kimchi-Sarfaty
Journal:  J Mol Biol       Date:  2013-08-03       Impact factor: 5.469

Review 3.  Hemophilia B: molecular pathogenesis and mutation analysis.

Authors:  A C Goodeve
Journal:  J Thromb Haemost       Date:  2015-05-18       Impact factor: 5.824

4.  Mutational Profiles of F8 and F9 in a Cohort of Haemophilia A and Haemophilia B Patients in the Multi-ethnic Malaysian Population.

Authors:  Maimiza Zahari; Siti Aishah Sulaiman; Zulhabri Othman; Yasmin Ayob; Faraizah Abd Karim; Rahman Jamal
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-09-01       Impact factor: 2.576

5.  ITPR1 gene p.Val1553Met mutation in Russian family with mild Spinocerebellar ataxia.

Authors:  M I Shadrina; M V Shulskaya; S A Klyushnikov; T Nikopensius; M Nelis; P A Kivistik; A A Komar; S A Limborska; S N Illarioshkin; P A Slominsky
Journal:  Cerebellum Ataxias       Date:  2016-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.